26 May 2013
Keywords: gsk, avandia, delays, deterioration, glucose, control, five-year
Article | 11 December 2006
UK drug major GlaxoSmithKline presented encouraging results from its ADOPT trial at the 19th World Diabetes Congress of the International
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 December 2006
24 May 2013
© 2013 thepharmaletter.com